Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | RP13-582O9.6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | NOP56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | C9orf3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | RPL7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SLC48A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | BCLAF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | TUBGCP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |